AI-generated summary
The authors systematically reviewed 35 human studies of transcranial photobiomodulation, a form of light therapy applied to the head, for cognitive function. They report that 29 of the 35 studies (82.9 percent) found positive cognitive improvement, and they conclude the approach seems to improve cognitive function. They also note that only about half of the clinical trials were randomized controlled trials, so further investigation is warranted.
- Studies included
- 35
- Who or what was studied
- Healthy adults and adults with cognitive disorders, including subjective memory complaints, mild cognitive impairment, dementia, traumatic brain injury, and stroke.
- Wavelengths
- 810, 630, 635, 1060, 1068 nm
- Limits stated in the abstract
- Only about half of the reviewed clinical trials were randomized controlled trials, and the authors call for further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 630-635 nm, 1060-1068 nm
- Energy density (fluence)
- 10 J/cm2
- Power density (irradiance)
- 25 mW/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Systematic review, Traumatic brain injury, Near-infrared, Mild cognitive impairment, Statistical significance, Brain injury. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.